249 related articles for article (PubMed ID: 25976565)
1. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
[TBL] [Abstract][Full Text] [Related]
2. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
3. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
4. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
6. From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm.
Martinez-Pinna R; Lindholt JS; Madrigal-Matute J; Blanco-Colio LM; Esteban-Salan M; Torres-Fonseca MM; Lefebvre T; Delbosc S; Laustsen J; Driss F; Vega de Ceniga M; Gouya L; Weiss G; Egido J; Meilhac O; Michel JB; Martin-Ventura J
Thromb Haemost; 2014 Jul; 112(1):87-95. PubMed ID: 24599423
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
8. Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease.
Chand S; Ward DG; Ng ZY; Hodson J; Kirby H; Steele P; Rooplal I; Bantugon F; Iqbal T; Tselepis C; Drayson MT; Whitelegg A; Chowrimootoo M; Borrows R
J Nephrol; 2015 Feb; 28(1):81-8. PubMed ID: 24687402
[TBL] [Abstract][Full Text] [Related]
9. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-carnitine and conjugated linoleic acid supplements on haemoglobin levels and haptoglobin genotype in chronic kidney disease.
Nemati A; Moghadam RA; Mazani M; Darvishi A
J Pak Med Assoc; 2019 Mar; 69(3):343-348. PubMed ID: 30890825
[TBL] [Abstract][Full Text] [Related]
11. Hepcidin, iron status, and inflammation variables among healthy pregnant women in the Turkish population.
Simavli S; Derbent AU; Uysal S; Turhan NÖ
J Matern Fetal Neonatal Med; 2014 Jan; 27(1):75-9. PubMed ID: 23662610
[TBL] [Abstract][Full Text] [Related]
12. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients.
Ford BA; Eby CS; Scott MG; Coyne DW
Kidney Int; 2010 Oct; 78(8):769-73. PubMed ID: 20668427
[TBL] [Abstract][Full Text] [Related]
15. The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease.
Gao Z; Hu Y; Gao Y; Ma X; Hu Z
Medicine (Baltimore); 2023 Apr; 102(17):e33558. PubMed ID: 37115087
[TBL] [Abstract][Full Text] [Related]
16. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
Xue D; He X; Zhou C
Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
[TBL] [Abstract][Full Text] [Related]
17. Correlation between hepcidin level and renal anemia.
Yang LN; Zhang P; Tang F; Wang G; Li FE
Genet Mol Res; 2014 Sep; 13(3):7407-10. PubMed ID: 25222239
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin and iron status among pregnant women in Bangladesh.
Schulze KJ; Christian P; Ruczinski I; Ray AL; Nath A; Wu LS; Semba RD
Asia Pac J Clin Nutr; 2008; 17(3):451-6. PubMed ID: 18818166
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
20. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
